Normalization of elevated liver enzymes due to V-1 Immunitor therapy
V-1 Immunitor (V1) is an oral AIDS vaccine currently being used as a therapeutic modality by HIV-positive patients. Upon interim analysis of phase I safety trial it has been discovered that patients who had elevated liver enzymes aspartate (AST/SGOT) and alanine (ALT/SGPT) aminotransferases have exp...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | English |
Publicado: |
Pontificia Universidad Católica de Valparaíso
2003
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582003000100010 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0717-34582003000100010 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0717-345820030001000102003-08-18Normalization of elevated liver enzymes due to V-1 Immunitor therapyJirathitikal,VichaiMetadilogkul,OrapunBourinbaiar,Aldar S. V-1 Immunitor (V1) is an oral AIDS vaccine currently being used as a therapeutic modality by HIV-positive patients. Upon interim analysis of phase I safety trial it has been discovered that patients who had elevated liver enzymes aspartate (AST/SGOT) and alanine (ALT/SGPT) aminotransferases have experienced the reduction of enzyme levels back to normal. Two other hepatitis markers alkaline phosphatase and bilirubin have also decreased. V1s effect may be hepatitis-specific since liver enzymes in normal patients treated with V1 have not changed and three patients who were Hepatitis B antigen positive at baseline became negative after therapy. The results suggest that V1 supplementation reduces hepatic damage caused by hepatitis viral infection.info:eu-repo/semantics/openAccessPontificia Universidad Católica de ValparaísoElectronic Journal of Biotechnology v.6 n.1 20032003-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582003000100010en |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
description |
V-1 Immunitor (V1) is an oral AIDS vaccine currently being used as a therapeutic modality by HIV-positive patients. Upon interim analysis of phase I safety trial it has been discovered that patients who had elevated liver enzymes aspartate (AST/SGOT) and alanine (ALT/SGPT) aminotransferases have experienced the reduction of enzyme levels back to normal. Two other hepatitis markers alkaline phosphatase and bilirubin have also decreased. V1s effect may be hepatitis-specific since liver enzymes in normal patients treated with V1 have not changed and three patients who were Hepatitis B antigen positive at baseline became negative after therapy. The results suggest that V1 supplementation reduces hepatic damage caused by hepatitis viral infection. |
author |
Jirathitikal,Vichai Metadilogkul,Orapun Bourinbaiar,Aldar S. |
spellingShingle |
Jirathitikal,Vichai Metadilogkul,Orapun Bourinbaiar,Aldar S. Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
author_facet |
Jirathitikal,Vichai Metadilogkul,Orapun Bourinbaiar,Aldar S. |
author_sort |
Jirathitikal,Vichai |
title |
Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
title_short |
Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
title_full |
Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
title_fullStr |
Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
title_full_unstemmed |
Normalization of elevated liver enzymes due to V-1 Immunitor therapy |
title_sort |
normalization of elevated liver enzymes due to v-1 immunitor therapy |
publisher |
Pontificia Universidad Católica de Valparaíso |
publishDate |
2003 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582003000100010 |
work_keys_str_mv |
AT jirathitikalvichai normalizationofelevatedliverenzymesduetov1immunitortherapy AT metadilogkulorapun normalizationofelevatedliverenzymesduetov1immunitortherapy AT bourinbaiaraldars normalizationofelevatedliverenzymesduetov1immunitortherapy |
_version_ |
1718441711344025600 |